menu toggle

Global consulting and market access

Transforming evidence and market intelligence into effective global market access strategies and solutions. 
global market access international consulting amerisourcebergen pharmalex

Delivering patients healthier futures wherever they are in the world

Our goal is to help you speed time to market and maximize your product’s success. As you pioneer the world’s most innovative therapies, Cencora is here to deliver key advantages to help you bridge the gap between good product launches and legendary ones.

  • Market access: Excel at transforming evidence into creative launch and pull-through campaigns with strong evidence and submission packages
  • HEOR and real-world evidence: Generate compelling evidence that resonates and communications your product's value
  • Policy navigation: Stay ahead by proactively navigating legislation
  • Market insights: Monitor the landscape and translate insights into actionable plans for growth

Our global capabilities

When launching products in Europe and HTA countries, we provide deep understanding of the environment, competition, and considerations for market access. We evaluate how your product many be viewed by payers and assess what may be needed beyond your clinical trials. We can help you engage early with key decision-makers and provide timely advice on strategy and execution.

Health economics & outcomes research

Work with industry-recognized experts who apply scientific methodologies to conduct the full scope of health economics and outcomes research for effective strategic planning. We combine rigorous, technical expertise with an understanding of local markets and multiple disease states to deliver relevant, transparent, and credible results to help inform practical strategies and tactics that communicate a robust portfolio of value-based evidence.

Market access consulting

When launching products outside the U.S., we provide deep understanding of the environment, competition, and considerations for market access across Europe and HTA countries. We evaluate how your product many be viewed by payers and assess what may be needed beyond your clinical trials. 

Real-world evidence

With strategic global data partnerships in the US, Germany, the UK, the Netherlands, France, Sweden, Canada, Japan, and China, we support our clients' global strategies along the entire product lifecycle.

Our databases are sourced from administrative claims, electronic medical records, or disease registries, and capture patient-level health information and outcomes for healthcare services performed in various care settings.

Regulatory affairs

Our global team offers the full range of regulatory services needed to enter and operate in international markets. Our strong foundation of technical, regulatory, and scientific expertise, makes us uniquely positioned to support pharmaceutical operations worldwide.

Patient Safety (Pharmacovigilance)

Along the whole product lifecycle from discovery through launch, our international team provides true end-to-end solutions for pharmacovigilance system & operation as well as benefit-risk-management services. Our global footprint enables us to cover all needs worldwide, on local affiliate level as well as for the global & headquarter functions.

Quality management and compliance

From innovation to commercialization, our global teams provide strategy consultancy on all things that impact the quality and compliance of the final product.

Biopharma companies looking to launch products in Europe need to understand – and plan for – the factors that influence the approval and decision-making processes related to reimbursement, coverage and pricing, such as the transition to European Union (EU) joint clinical assessments, which will start for oncology and advanced therapies in 2025 as part of new health technology assessment (HTA) processes. Cencora consultants have the expertise and experience required to help you navigate your next global launch against rapidly evolving markets."

Tommy Bramley, PhD
Senior Vice President, Market Access and Healthcare Consulting
Cencora

See our market access and consulting insights

meeting

Insight

5 questions with Jane Ha

Jane Ha, PharmD, MS
AmerisourceBergen
May 2024

meeting

Insight

6 questions with Kyle Noonan

Kyle Noonan, PharmD, MS
AmerisourceBergen
May 2024

Chemical chain

Insight

Webinar: Bracing for the Impact of Biosimilars: Navigating Terrain in the U.S. Market Landscape

FormularyDecisions
AmerisourceBergen
May 2024

subscribe to HTA quarterly

HTA Quarterly

Each edition of HTA Quarterly provides insights and analysis from global experts with local market expertise on key priorities and perspectives affecting HTA. From therapeutic area spotlights to geographic reviews to critical industry topics, keep current on HTA activity around the globe with HTA Quarterly. Browse the archive and subscribe to the quarterly newsletter today. 

We are Cencora. Our shared identity unites us.

Cencora brings the companies and services of AmerisourceBergen together under one new name. Check out our full life cycle commercialization solutions, and contact us today to learn more.